Short Description

Acute Myeloid Leukemia (AML) is one of the most common Leukemias and also comprises 15% of pediatric Acute Leukemias. This assay helps to identify cytogenetic abnormalities in patients with myeloid malignancies and tracking response to therapies. Detection of an abnormal clone indicates a diagnosis of AML of various subtypes.

PreTest Information

No special preparation required

Detail Description

AML CATEGORIZATION PCR Test Cost - DNA Labs India

Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow. It is characterized by the rapid and abnormal growth of white blood cells in the bone marrow, which can lead to life-threatening complications. AML categorization PCR test is a diagnostic tool used to identify specific genetic mutations in AML patients. This test is offered by DNA Labs India at a cost of INR 10500.

Symptoms of AML

The symptoms of AML can vary from person to person and may include:

• Fever
• Fatigue
• Shortness of breath
• Bruising or bleeding easily
• Weakness
• Pale skin
• Swollen lymph nodes
• Abdominal pain or swelling
• Loss of appetite
• Sudden weight loss

If you experience any of these symptoms, it is important to see a doctor for an accurate diagnosis.

Diagnosis of AML

To diagnose AML, your doctor may perform a physical exam, blood tests, and bone marrow biopsy. The AML categorization PCR test is a genetic test that can help identify specific mutations that may be present in AML patients. This test can help doctors determine the best course of treatment for patients with AML.

Cost of AML Categorization PCR Test

The cost of AML categorization PCR test at DNA Labs India is INR 10500. This test is performed using advanced technology and by experienced professionals to ensure accurate results.

Conclusion

AML is a serious condition that requires prompt diagnosis and treatment. The AML categorization PCR test is an important diagnostic tool that can help identify specific genetic mutations in AML patients. If you or a loved one is experiencing symptoms of AML, it is important to see a doctor for an accurate diagnosis. For more information about the AML categorization PCR test, contact DNA Labs India today.

AML categorization using PCR (polymerase chain reaction) is a molecular diagnostic technique used to classify and subtype acute myeloid leukemia (AML). AML is a type of cancer that affects the bone marrow and blood. It is characterized by the rapid growth of abnormal white blood cells, which can interfere with the production of normal blood cells.

The PCR test in AML categorization is used to detect specific genetic mutations or abnormalities in the leukemia cells. These mutations play a significant role in determining the prognosis of the disease and in guiding treatment decisions. PCR is a sensitive technique that can detect even very small amounts of genetic material.

Here's how the AML categorization PCR test works:

1. Sample Collection: A sample of bone marrow or blood is collected from the patient. The sample contains leukemia cells that are analyzed for genetic mutations.

2. DNA Extraction: The genetic material (DNA) is extracted from the collected sample. This DNA contains the genetic information of the leukemia cells.

3. PCR Amplification: PCR is used to amplify specific DNA sequences that are associated with known genetic mutations or abnormalities in AML. This involves making millions of copies of the targeted DNA region.

4. Mutation Detection: The amplified DNA is then analyzed to determine whether specific mutations or genetic markers are present. Different mutations can indicate different subtypes of AML and can guide treatment decisions.

5. Categorization and Subtyping: Based on the presence or absence of specific genetic mutations, the leukemia cells are categorized into different subtypes of AML. This categorization is crucial for determining prognosis and selecting the most appropriate treatment approach.

Common genetic mutations tested for using PCR in AML include mutations in genes such as FLT3, NPM1, CEBPA, and others. These mutations provide important information about disease aggressiveness, response to treatment, and overall prognosis.

It's important to note that AML categorization using PCR is just one part of the overall diagnostic and treatment process. The results of this test are usually interpreted by a hematopathologist or oncologist who specializes in blood disorders and cancer. The information obtained from the PCR test, along with other clinical and laboratory findings, helps healthcare providers make informed decisions about the most appropriate treatment plan for each patient.